- Home
- EXP vs RVMD Comparison
EXP vs RVMD Comparison
Compare EXP & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXP
- RVMD
- Stock Information
- Founded
- EXP 1963
- RVMD 2014
- Country
- EXP United States
- RVMD United States
- Employees
- EXP 2500
- RVMD N/A
- Industry
- EXP Building Materials
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EXP Industrials
- RVMD Health Care
- Exchange
- EXP Nasdaq
- RVMD Nasdaq
- Market Cap
- EXP 7.6B
- RVMD 7.5B
- IPO Year
- EXP 1994
- RVMD 2020
- Fundamental
- Price
- EXP $233.82
- RVMD $44.70
- Analyst Decision
- EXP Buy
- RVMD Strong Buy
- Analyst Count
- EXP 9
- RVMD 16
- Target Price
- EXP $263.11
- RVMD $73.56
- AVG Volume (30 Days)
- EXP 302.5K
- RVMD 2.0M
- Earning Date
- EXP 10-28-2025
- RVMD 11-05-2025
- Dividend Yield
- EXP 0.42%
- RVMD N/A
- EPS Growth
- EXP N/A
- RVMD N/A
- EPS
- EXP 13.58
- RVMD N/A
- Revenue
- EXP $2,286,509,000.00
- RVMD N/A
- Revenue This Year
- EXP $3.61
- RVMD N/A
- Revenue Next Year
- EXP $4.65
- RVMD $454.11
- P/E Ratio
- EXP $17.36
- RVMD N/A
- Revenue Growth
- EXP 0.88
- RVMD N/A
- 52 Week Low
- EXP $191.91
- RVMD $29.17
- 52 Week High
- EXP $321.93
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- EXP 52.47
- RVMD 67.71
- Support Level
- EXP $227.09
- RVMD $39.73
- Resistance Level
- EXP $238.20
- RVMD $47.21
- Average True Range (ATR)
- EXP 5.78
- RVMD 1.88
- MACD
- EXP -0.33
- RVMD 0.77
- Stochastic Oscillator
- EXP 57.41
- RVMD 78.31
About EXP Eagle Materials Inc
Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.